Computational Simulations to Guide Enzyme-Mediated Prodrug Activation
Open Access
- 19 May 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (10), 3621
- https://doi.org/10.3390/ijms21103621
Abstract
Prodrugs are designed to improve pharmaceutical/biopharmaceutical characteristics, pharmacokinetic/pharmacodynamic properties, site-specificity, and more. A crucial step in successful prodrug is its activation, which releases the active parent drug, exerting a therapeutic effect. Prodrug activation can be based on oxidation/reduction processes, or through enzyme-mediated hydrolysis, from oxidoreductases (i.e., Cytochrome P450) to hydrolytic enzymes (i.e., carboxylesterase). This study provides an overview of the novel in silico methods for the optimization of enzyme-mediated prodrug activation. Computational methods simulating enzyme-substrate binding can be simpler like molecular docking, or more complex, such as quantum mechanics (QM), molecular mechanics (MM), and free energy perturbation (FEP) methods such as molecular dynamics (MD). Examples for MD simulations used for elucidating the mechanism of prodrug (losartan, paclitaxel derivatives) metabolism via CYP450 enzyme are presented, as well as an MD simulation for optimizing linker length in phospholipid-based prodrugs. Molecular docking investigating quinazolinone prodrugs as substrates for alkaline phosphatase is also presented, as well as QM and MD simulations used for optimal fit of different prodrugs within the human carboxylesterase 1 catalytical site. Overall, high quality computational simulations may show good agreement with experimental results, and should be used early in the prodrug development process.This publication has 72 references indexed in Scilit:
- Prodrugs of Acyclovir – A Computational ApproachChemical Biology & Drug Design, 2012
- Enhancing the Intestinal Membrane Permeability of Zanamivir: A Carrier Mediated Prodrug ApproachMolecular Pharmaceutics, 2011
- Specificity of a Prodrug-Activating Enzyme hVACVase: The Leaving Group EffectMolecular Pharmaceutics, 2010
- Enhancing the Intestinal Absorption of Molecules Containing the Polar Guanidino Functionality: A Double-Targeted Prodrug ApproachJournal of Medicinal Chemistry, 2009
- Progress in Ab Initio QM/MM Free-Energy Simulations of Electrostatic Energies in Proteins: Accelerated QM/MM Studies of pKa, Redox Reactions and Solvation Free EnergiesThe Journal of Physical Chemistry B, 2008
- Molecular Basis of Prodrug Activation by Human Valacyclovirase, an α-Amino Acid Ester HydrolaseJournal of Biological Chemistry, 2008
- Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approachChemico-Biological Interactions, 2008
- Molecular Basis of Phospholipase A2 Activity toward Phospholipids with sn-1 SubstitutionsBiophysical Journal, 2008
- Modelling enzyme reaction mechanisms, specificity and catalysisDrug Discovery Today, 2005
- Molecular modeling methods. Basic techniques and challenging problemsPharmacology & Therapeutics, 1993